Treatment of hepatocellular carcinoma in patients with cirrhosis
References (114)
- et al.
Etiology, screening, and treatment of hepatocellular carcinoma
Med Clin North Am
(1996) - et al.
Natural history of hepatocellular carcinoma. Five year's experience in 249 cases
J Hepatol
(1990) - et al.
Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: a randomized, controlled trial
Hepatoloty
(1995) - et al.
Microwave coagulation therapy for hepatocellular carcinoma
Gastroenterology
(1996) - et al.
Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma
Hepatology
(1995) - et al.
Progress in orthotopic liver transplantation for hepatocellular carcinoma
Gastroenterology
(1993) Liver transplantation for malignant disease
Gastroenterol Clin North Am
(1993)- et al.
Liver transplantation for primary hepatocellular carcinoma. Tumor size and number determine outcome
J Hepatol
(1993) - et al.
Liver transplantation for hepatitis-B
Gastroenterol Clin North Ann
(1993) Liver transplantation for chronic hepatitis-C viral infection
Gastroenterol Clin North Am
(1993)
Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection
Gastroenterology
Hepatic resection of hepatocellular carcinoma in cirrhotic livers: is it unjustified in impaired liver function
Surgery
Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure
Gastroenterology
Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma
Gastroenterology
Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma
Hepatology
Surgical resection for small hepatocellular carcinoma
Surgery
Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma
Gastroenterology
DNA ploidy pattern in synchronous and metachronous hepatocellular carcinomas
J Hepatol
Clonal origin of recurrent hepatocellular carcinomas
Gastroenterology
Adult cirrhotic liver explants: precancerous lesions and undetected small hepatocellular carcinomas
Gastroenterology
Asymptomatic hepatocellular carcinoma in Child's A cirrhosis. A comparison of natural history and surgical treatment
Gastroenterology
Treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis
J Hepatol
Surgical resection and survival in Western patients with hepatocellular carcinoma
J Hepatol
Primary treatment of hepatocellular carcinoma by arterial chemoembolization
Am J Surg
A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma
J Hepatol
Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma
J Hepatol
Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma. A randomized controlled trial
Gastroenterology
Sex hormone receptors in hepatocellular carcinoma. Is there a rationale for hormonal treatment?
J Hepatol
Hepatocellular carcinoma in cirrhotics
Semin Liver Dis
Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients
Cancer
Prognostic factors of hepatocellular carcinoma in the West. A multivariate analysis in 206 patients
Hepatology
Prognostic factors in patients with hepatocellular carcinoma. Attempts for the selection of patients with prolonged survival
Cancer
The natural history of hepatocellular carcinoma. A study of 100 untreated cases
Cancer
Prognosis of hepatocellular carcinoma smaller than 5 cm in relation to treatment. Study of 100 patients
Hepatology
Prognostic factors for survival in hepatocellular carcinoma
Cancer Res
Gross anatomic features of hepatocellular carcinoma from three disparate geographic areas. Proposal of new classification
Cancer
Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma
Cancer
Recombinant interferon-alpha in inoperable hepatocellular carcinoma. A randomized controlled trial
Hepatology
Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support
J Nucl Med
Radioembolisation of hepatocellular carcinoma with 90-yttrium resin particles
Eur Radiol
Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation
Cancer
Role of liver transplantation in the treatment of hepatocellular carcinoma
Semin Surg Oncol
Comparison of hepatic resection and transplantation in the treatment of liver cancer
Semin Surg Oncol
Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients
World J Surg
Indications for liver transplantation in hepatobiliary malignancy
Hepatology
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
N Engl J Med
Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients
Ann Surg
Treatment of small hepatocellular carcinoma in cirrhotic patients. A cohort study comparing surgical resection and percutaneous ethanol injection
Hepatology
Small hepatocellular carcinoma in patients undergoing liver transplantation: detection with CT after injection of iodized oil
Radiology
Adjuvant chemotherapy improves survival aftr liver transplantation for hepatocellular carcinoma
Ann Surg
Cited by (67)
Pre-Liver Transplantation Locoregional Adjuvant Therapy for Hepatocellular Carcinoma as a Strategy to Improve Longterm Survival
2006, Journal of the American College of SurgeonsTranscatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: A case-controlled study
2005, Clinical Gastroenterology and HepatologyCurrent role of portal vein embolization/hepatic artery chemoembolization
2004, Surgical Clinics of North AmericaHerpes simplex virus thymidine kinase-mediated suicide gene therapy for hepatocellular carcinoma using HIV-1-derived lentiviral vectors
2004, Journal of HepatologyCitation Excerpt :The incidence of hepatocellular carcinoma (HCC), a tumor usually associated with liver cirrhosis or chronic infection with hepatitis B or C viruses, [1,2] is seeing sustained growth in Europe, Japan and USA [3,4]. Treatment for this cancer remains difficult; tumor resection or liver transplantation cannot be proposed to most patients because of their underlying liver disease or extension of the tumor at the time of diagnosis [5–8]. Gene therapy may constitute an attractive therapeutic alternative for HCC.
Etiology of hepatocellular carcinoma influences clinical and pathologic features but not patient survival
2003, American Journal of GastroenterologyCitation Excerpt :The severity of liver disease and the characteristics of the neoplasm are the main prognostic factors, and have been included in the traditional (5) and more recently proposed (6–9) prognostic classification systems. It has been suggested that both the natural history and the presentation of HCC at diagnosis may depend on the cause of the underlying chronic liver disease (10). Hepatitis B virus (HBV), hepatitis C virus (HCV), and alcohol intake have been definitely recognized as the main causes of HCC in developed countries (11, 12) and are responsible for most cases of cirrhosis (13, 14) and HCC (15–17) in Italy.